A Randomized Phase II and Pharmacokinetic Study of the Antisense Oligonucleotides ISIS 3521 and ISIS 5132 in Patients with Hormone-refractory Prostate Cancer1
Clin Cancer Res (2002) 8 (8): 2530–2535.
Currently there are no citedby results. Try again later.
